Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: A randomized controlled trial

Obstetrics and Gynecology

Volumn 112, Issue 5, 2008, Pages 990-997

  Sawaya, George F ^a   Chirenje, Mike Zvavahera ^a   Magure, Mildred Tsitsi ^a   Tuveson, Jennifer L ^a   Ma, Yifei ^a   Shiboski, Stephen C ^a   Da Costa, Maria M ^a   Palefsky, Joel M ^a   Moscicki, Anna Barbara ^a   Mutasa, Rudo Makunike ^a   Chipato, Tsungai ^a   Smith Mccune, Karen K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LATEX; LUBRICATING AGENT; AGENTS USED INTRAVAGINALLY;

ADULT; ARTICLE; CLEARANCE; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEXUAL BEHAVIOR; VIRUS INFECTION; WART VIRUS; ZIMBABWE; ALPHAPAPILLOMAVIRUS; FEMALE CONTRACEPTIVE DEVICE; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD;

ALPHAPAPILLOMAVIRUS; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; PAPILLOMAVIRUS INFECTIONS; VAGINAL CREAMS, FOAMS, AND JELLIES; ZIMBABWE;

EID: 58149279817     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318189a8a4     Document Type: Article

References (21)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
2. Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, et al. HPV and cervical cancer in the world 2007 report. Vaccine 2007;25 suppl:C1-230.
3. Sawaya GF, Smith-McCune K. HPV vaccination-more answers, more questions. N Engl J Med 2007;356:1991-3.
4. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillo-mavirus infection in young women. N Engl J Med 2006;354: 2645-54.
5. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillo-mavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
6. Kjaer SK. Risk factors for cervical neoplasia in Denmark. APMIS Suppl 1998;80:1-41.
7. Kjaer SK, de Villiers EM, Caglayan H, Svare E, Haugaard BJ, Engholm G, et al. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark) - a second look. Br J Cancer 1993;67:830-7.
8. Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithe-lial lesion development. J Womens Health Gend Based Med 2001;10:441-9.
9. Parazzini F, Negri E, La Vecchia C, Fedele L. Barrier methods of contraception and the risk of cervical neoplasia. Contraception 1989;40:519-30.
10. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 1986; 77:1063-77.
11. Wright NH, Vessey MP, Kenward B, McPherson K, Doll R. Neoplasia and dysplasia of the cervix uteri and contraception: a possible protective effect of the diaphragm. Br J Cancer 1978;38:273-9.
12. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. Am J Epidemiol 1987; 126:592-604.
13. Jones CJ, Brinton LA, Hamman RF, Stolley PD, Lehman HF, Levine RS, et al. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990;50:3657-62.
14. Fasal E, Simmons ME, Kampert JB. Factors associated with high and low risk of cervical neoplasia. J Natl Cancer Inst 1981;66:631-6.
15. Becker TM, Wheeler CM, McGough NS, Stidley CA, Parmenter CA, Dorin MH, et al. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Int J Epidemiol 1994;23: 913-22.
16. U.S. Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions: report of the U.S. Preventive Services Task Force. Baltimore (MD): Williams & Wilkins;1996.
17. Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003; 107:811-6.
18. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370:251-61.
19. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7.
20. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papil-lomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
21. Smith-McCune KK, Tuveson JL, Rubin MM, DaCosta MM, Darragh TM, Shiboski SC, et al. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis 2006;10:213-8.